HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Claims Advocates Suggest FDA Pull New Dietary Ingredient Guidance

This article was originally published in The Tan Sheet

Executive Summary

Citizens for Health makes more radical comments than most about NDI notification FDA’s draft guidance, asking the agency to withdraw it. The group further asks FDA to declare that it “will not, now or ever” enforce under any “re-interpretation” of DSHEA.

You may also be interested in...



Jarrow Formulas Founder Forms “More Creative” Supplement Trade Group

A dietary supplement trade group founded by Jarrow Rogovin plans to aggressively protect the industry’s interests, including filing lawsuits and Freedom of Information Act requests.

Herbal Firm Denied Supreme Court Hearing Over Cancer Claim

The Supreme Court will not consider herbal supplement marketer Daniel Chapter One's argument that the right to freedom of religion allows the firm to claim its products cure cancer.

US FDA ‘Punt’ On Hemp Rulemaking Frustrates, Confuses Supplement Industry

Industry trade groups say FDA decision against starting rulemaking for lawful use of hemp ingredients is not only overdue but failed to clear the air for businesses making or using the ingredients.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS125215

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel